Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Spyre Therapeutics, Inc. | 140,000 | reported | 09 Jan 2026 | tx 4+13,793,755 |
| Axcella Health Inc. | 35,000 | reported | 18 Dec 2019 | tx 1+35,000 |
| Provention Bio, Inc. | 0 | reported | 27 Apr 2023 | tx 11+664,500−1,084,500 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 09 Jan 2026 | GRANT_AWARD | Spyre Therapeutics, Inc. | 140,000 | 0.00 USD | deriv |
| 15 Jan 2025 | GRANT_AWARD | Spyre Therapeutics, Inc. | 95,500 | 0.00 USD | deriv |
| 01 Feb 2024 | GRANT_AWARD | Spyre Therapeutics, Inc. | 63,000 | 0.00 USD | deriv |
| 01 Sept 2023 | GRANT_AWARD | Spyre Therapeutics, Inc. | 13,495,255 | 0.00 USD | deriv |
| 27 Apr 2023 | OTHER | Provention Bio, Inc. | 139,500 | — | deriv |
| 27 Apr 2023 | OTHER | Provention Bio, Inc. | 145,000 | — | deriv |
| 27 Apr 2023 | OTHER | Provention Bio, Inc. | 200,000 | — | deriv |
| 27 Apr 2023 | OTHER | Provention Bio, Inc. | 300,000 | — | deriv |
| 10 Jan 2023 | GRANT_AWARD | Provention Bio, Inc. | 200,000 | 0.00 USD | deriv |
| 22 Nov 2022 | GRANT_AWARD | Provention Bio, Inc. | 90,000 | 0.00 USD | deriv |
| 22 Mar 2022 | GRANT_AWARD | Provention Bio, Inc. | 60,000 | 0.00 USD | deriv |
| 18 Jan 2022 | GRANT_AWARD | Provention Bio, Inc. | 145,000 | 0.00 USD | deriv |
| 03 Aug 2021 | GRANT_AWARD | Provention Bio, Inc. | 30,000 | 0.00 USD | deriv |
| 12 May 2021 | GRANT_AWARD | Provention Bio, Inc. | 139,500 | 0.00 USD | deriv |
| 03 Aug 2020 | GRANT_AWARD | Provention Bio, Inc. | 300,000 | 0.00 USD | deriv |
| 18 Dec 2019 | GRANT_AWARD | Axcella Health Inc. | 35,000 | 0.00 USD | deriv |